Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma.

Jun LiuYang YangZhi-Chao LiuXiaolong FuXiaoyue CaiHongxuan LiLi ZhuYan ShenHong ZhangYifeng SunHezhong ChenBentong YuRenquan ZhangJinchen ShaoMing ZhangZhi-Gang Li

Published in: Journal for immunotherapy of cancer (2022)

ChiCTR1900026240.

Keyphrases

locally advanced
rectal cancer
lymph node
open label
randomized controlled trial
radiation therapy
combination therapy
smoking cessation